FFO
PRAX icon

Fortitude Family Office’s Praxis Precision Medicines PRAX Stock Holding History

Fortitude Family Office’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$670 Sell
2
-5
-71% -$1.58K ﹤0.01% 1896
2026
Q1 		$2.25K Buy
+7
New +$2.17K ﹤0.01% 1248

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Fortitude Family Office's PRAX Position: Q2 2026 in Review

Fortitude Family Office reduced its Praxis Precision Medicines (PRAX) stake by 71% in Q2 2026, selling an estimated $1.58K and leaving 2 shares worth $670. The position accounts for ﹤0.01% of the portfolio, ranked #1896.

Fortitude Family Office first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.25K in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Fortitude Family Office held 2 shares of Praxis Precision Medicines worth $670 as of Q2 2026.
  • Fortitude Family Office sold 5 Praxis Precision Medicines shares in Q2 2026, an estimated $1.58K.
  • Praxis Precision Medicines made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1896 holding.
  • Fortitude Family Office first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
  • Fortitude Family Office's Praxis Precision Medicines position peaked at $2.25K in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.